MenACWY

Meningococcal conjugate vaccine A/C/W-135/Y · Novartis

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MenACWY, covering 2012-10-16 to 2019-06-07. Get the full timeline:

Most recent: Clinical Trial Update: The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination [Phase 3]

See pricing